News

Eczema associated with childhood speech disorder


 

References

Pediatric eczema was significantly associated with a higher risk of speech disorder, reported Dr. Mark A. Strom and his coauthors from Northwestern University, Chicago.

A retrospective analysis of 354,416 children in 19 U.S. population–based cohorts found that the prevalence of speech disorder was 4.7% among the children with eczema (95% confidence interval, 4.5%-5.0%), compared with 2.2% among those without eczema (95% CI; 2.2%-2.3%).

Results from a multivariate analysis showed that eczema was associated with increased odds of speech disorder (adjusted odds ratio = 1.81 [1.57-2.05]; P less than .001). Mild (1.36 [1.02-1.81]; P = .03) and severe (3.56 [1.70-7.48]; P less than .001) eczema were associated with higher risk of speech disorder, the investigators said.

The findings were based on results from the 2003-2004 and 2007-2008 National Survey of Children’s Health, and the 1997-2013 National Health Interview Survey.

Read the study in the Journal of Pediatrics.

Recommended Reading

Aspirin desensitization making headway in U.S.
MDedge Pediatrics
Safely patch test children for contact dermatitis
MDedge Pediatrics
WCD: Topical tofacitinib hits marks in atopic dermatitis
MDedge Pediatrics
WCD: Pramocaine is a common contact sensitizer
MDedge Pediatrics
AAP: Give peanut products to high-risk infants to cut allergy risk
MDedge Pediatrics
Peripartum probiotics linked to lower atopic dermatitis risk in offspring
MDedge Pediatrics
Study links childhood type 1 diabetes to increased AD risk
MDedge Pediatrics
EADV: Novel topical crisaborole shines in atopic dermatitis
MDedge Pediatrics
EADV: Another promising topical for atopic dermatitis
MDedge Pediatrics
Busting eczema treatment myths: applying the evidence
MDedge Pediatrics